The Oncology Institute announced the resignation of Gabe Ling from the Board of Directors.
A search for new independent directors with healthcare expertise has been initiated.
The company aims to enhance its governance structure for long-term growth goals.
Resignation of Gabe Ling
Gabe Ling resigned from the Board of Directors, effective December 1, 2025.
Search for New Directors
Formal search process started to bring on new independent directors with healthcare and value-based care expertise.
Board's Appreciation
The Board expressed gratitude for Gabe Ling's contributions during the company's development.
- The departure of Gabe Ling will lead to the addition of new directors with specialized healthcare knowledge.
- Enhancing the Board's capabilities is crucial for supporting The Oncology Institute's mission and growth objectives.
The Oncology Institute is focused on strengthening its governance structure by recruiting experienced directors to support its long-term vision and growth.